Sosei Archives -

Japanese biotech Sosei’s buyout of the UK’s Heptares four years ago has rewarded it with a string of

Sosei Heptares bags another big partnership, this time with Takeda

https://pharmaphorum.com/news/sosei-heptares-bags-another-big-partnership-this-time-with-takeda/

Roche’s Genentech unit signed a trio of deals this week to add new drug discovery platforms to its

Genentech extends small-molecule R&D with three platform deals

https://pharmaphorum.com/news/genentech-extends-small-molecule-rd-with-three-platform-deals/

Pfizer has selected the first drug candidate from a collaboration with Sosei Group to develop drugs for major

Pfizer selects first GPCR candidate from Sosei Heptares tie-up

https://pharmaphorum.com/news/pfizer-selects-first-gpcr-candidate-from-sosei-heptares-tie-up/

Sosei has announced that its founder and former CEO Shinichi Tamura will be re-taking the position of CEO

Shinichi Tamura re-takes CEO role at Sosei

https://pharmaphorum.com/news/shinichi-tamura-re-takes-ceo-role-sosei/

Allergan and Sosei’s experimental Alzheimer’s medicine has run into trouble – the companies have called a halt to

Sosei shares tank after safety issue with Alzheimer’s drug

https://pharmaphorum.com/news/sosei-shares-tank-after-safety-issue-with-alzheimers-drug/

Troubled generics giant Teva is continuing the heavy pruning of its business and has cut a novel migraine drug from its pipeline.

Sosei see Teva pipeline cull as an opportunity

https://pharmaphorum.com/news/sosei-loses-teva-culls-migraine-pipeline/

Sosei